Luba Greenwood

Luba Greenwood

Direttore/Membro del Consiglio presso IN8BIO, INC.

Patrimonio netto: 16 424 $ in data 31/05/2026

47 anni
Health Technology
Finance
Consumer Services

Profilo

Luba Greenwood was the founder of LUCA Biologics, Inc., founded in 2019, serving as Chief Executive Officer & Director from 2019 to 2021.
Ms. Greenwood is also the founder of Pharma Digital Health Roundtable..
Ms. Greenwood is a Non-Executive Director at Abcam Ltd. (United Kingdom) since 2022.
Ms. Greenwood is a Director at Massachusetts Biotechnology Council, Entrinsic, Inc. (Massachusetts), and Scinapsis Analytics, Inc. since 2021.
Ms. Greenwood is an Independent Director at Os Acquisition Corp.
and IN8bio, Inc. since 2021.
Ms. Greenwood is a Professor at Harvard University since 2019.
Ms. Greenwood is an Advisor at CHV Management LLC, Van Leer Xenia Ventures, and Stuff That Works Ltd. since 2021.
Ms. Greenwood is a Managing Partner at Dana-Farber, Inc., Binney Street Capital since 2020, and Cathay Capital Private Equity SAS. Ms. Greenwood is a Senior Advisor at Grove Ventures Capital (GP) Ltd. Ms. Greenwood is a Member of the Massachusetts Board of Bar Overseers.
Former positions include Director at IRX Therapeutics, Inc., Longwood Symphony Orchestra, Inc. in 2016, Brooklyn Immunotherapeutics Investors LP from 2017 to 2022, Kojin Therapeutics, Inc. in 2021, Ernexa Therapeutics, Inc. from 2021 to 2022, and Traws Pharma, Inc. in 2024.
Senior counsel at Pfizer Inc. from 2011 to 2014.
Vice President-Global Business Development at F.
Hoffmann-La Roche Ltd. and Roche Holding AG from 2015 to 2018.
Venture partner at Colt Ventures Ltd. in 2015.
Vice president at Axcella Health, Inc. from 2014 to 2015.
Head-Strategic Business Development at Verily Life Sciences LLC from 2018 to 2019.
Executive Managing Partner at Dana-Farber Cancer Institute, Inc. from 2019 to 2024.
Senior Associate at WilmerHale LLP from 2004 to 2011.
Managing Partner at The Cathay Capital Group.
Education includes undergraduate degree from Brandeis University and graduate degree from Northeastern University School of Law.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
09/05/2026 8.783 ( 0,09% ) 16 424 $ 31/05/2026

Posizioni attive di Luba Greenwood

SocietàPosizioneInizio
IN8BIO, INC. Direttore/Membro del Consiglio 01/07/2021
ABCAM PLC Direttore/Membro del Consiglio 12/09/2022
Consulente / Consigliere -
Corporate Officer/Principal 01/06/2019
Corporate Officer/Principal -
Consulente / Consigliere 01/01/2021
Consulente / Consigliere -
Consulente / Consigliere -
Investitore di Private Equity -
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -

Precedenti posizioni note di Luba Greenwood

SocietàPosizioneFine
░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ -
Vedi nel dettaglio l'esperienza di Luba Greenwood

Formazione di Luba Greenwood

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

66

Relazioni di 1° grado

34

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private34

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Finance

Commercial Services

Finance

Finance

Health Technology

Consumer Services

Finance

Technology Services

Technology Services

Finance

Technology Services

Commercial Services

Health Technology

Finance

The Cathay Capital Group

Health Technology

Health Technology

Technology Services

Finance

Health Technology

Finance

Pharma Digital Health Roundtable

Commercial Services

Consumer Services

  1. Mercati
  2. Insiders
  3. Luba Greenwood
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA